| NCT Number | NCT07042191 |
| Lead Sponsor | Barbara Ann Karmanos Cancer Institute |
| Conditions | Healthy, Financial Toxicity |
| Enrollment | 24 participants |
| Start Date | 2022-12-09 |
| Primary Completion | 2027-07 (estimated) |
| Study Completion | 2027-07 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-06 |